- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- TRANSCRIPTION FACTOR PU.1 IS A TARGET OF 5-AZACITIDINE DURING DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMEPublication without faculty affiliation
